Paolo Calzari
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Patch test sensitization and permanent tattoos: epidemiological data from two referral centers.
Journal: European annals of allergy and clinical immunology
Published: June 10, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.
Journal: Clinical and experimental dermatology
Published: April 12, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Journal: Dermatology and therapy
Published: March 11, 2026
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series.
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 17, 2026
Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck Involvement.
Journal: Dermatology and therapy
Published: December 19, 2025
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: November 07, 2025
Exercise-induced vasculitis with histological and genetic evidence of complement involvement.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: October 22, 2025
Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria.
Journal: Frontiers in allergy
Published: October 20, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: August 12, 2025
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center.
Journal: International journal of dermatology
Published: July 15, 2025
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis.
Journal: Clinical and experimental dermatology
Published: April 04, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes.
Journal: Journal of clinical medicine
Published: February 05, 2025
Last Updated: 09/26/2026